
Limited Series
- 1 The Spark
- 2 First Impressions
- 3 Where's My Juul?
- 4 Overnight Billionaires

In this docuseries, a scrappy electronic cigarette startup becomes a multibillion-dollar company until an epidemic causes its success to go up in smoke.
Latest episode: S1 E4 Overnight Billionaires (Oct 11, 2023)

Official
I’ve seen this movie before—literally. The Silicon Valley origin story: two idealistic young founders with a disruptive idea, a sleek product that promises to change the world, and a meteoric rise followed by a spectacular fall. The Social Network, WeWork: Or the Making and Breaking of a a reported budget Unicorn, The Inventor—the genre has become its own kind of comfort food, a morality play where capitalism’s excesses are exposed with just enough schadenfreude to make us feel better about our own modest lives. Big Vape: The Rise and Fall of Juul, Netflix’s four-part docuseries, fits neatly into this canon, but with a twist: its cautionary tale isn’t just about hubris or greed. It’s about how a company sold addiction as innovation, and how that addiction became a public health crisis before anyone could hit pause.

The series opens with a familiar Silicon Valley tableau: two Stanford design graduates, Adam Bowen and James Monsees, tinkering in a garage. Their mission? To create a better e-cigarette, one that could help adult smokers quit.
The result was Juul, a device so sleek and user-friendly it was dubbed the “iPhone of e-cigs.” Early on, the docuseries leans into this narrative, presenting Juul as a scrappy startup with a noble goal. But as the episodes unfold, the cracks in that story become impossible to ignore. The “Fuck it, ship it” internal culture, the leaked memos about pod leakage, the “Vaporized” marketing campaign that recruited youth influencers—these aren’t just missteps.
They’re the blueprint for a company that prioritized growth over safety, and cool over consequences.
What makes Big Vape more than just another tech takedown is its refusal to let Juul off the hook for the human cost of its success. The series doesn’t just rely on talking heads—though there are plenty of those, from former employees to tobacco historians—to make its case. It lets the numbers speak for themselves: by 2018, Juul controlled 75% of the U.S.
E-cigarette market, and its products were being used by 20% of high school students. The docuseries weaves in footage of teens vaping in school bathrooms, their faces a mix of defiance and sheepishness, as if they know they’re part of something bigger than themselves but can’t quite articulate what. It’s a chilling reminder that addiction isn’t just a personal failing; it’s a business model.

The series’ most damning moments come from the mouths of Juul’s own employees. One former recruiter, Allen Gladstone, describes the company’s culture as “a mix of arrogance and naivety,” a place where the urgency to scale overshadowed any concerns about the product’s impact. Another interviewee, NYU tobacco expert Cheryl Healton, puts it bluntly: “They didn’t care who used it, as long as someone did.” These aren’t just soundbites; they’re admissions of a company that lost its way—or maybe never had a moral compass to begin with. The Daily Beast called the series “nothing very hazy about the damning portrait it paints,” and they’re right.
The docuseries doesn’t equivocate. It lays out the evidence, connects the dots, and lets the viewer draw their own conclusions. But the conclusion is hard to avoid: Juul didn’t just stumble into controversy.
It ran toward it, eyes wide open.
That said, Big Vape isn’t without its flaws. Some critics have argued that the series gives too much airtime to pro-vaping voices, as if it’s bending over backward to appear “balanced.” Common Sense Media, for instance, praised the docuseries for asking “hard questions of the tech industry’s ‘go fast’ model” but cautioned that it doesn’t resolve the health hazard debate clearly.
And they’re right to point that out. The series includes perspectives from tobacco harm reduction advocates who argue that Juul’s product could have helped adult smokers quit, if only the company had marketed it responsibly. It’s a valid point, but it also feels like a distraction from the larger issue: that Juul’s marketing wasn’t just irresponsible—it was predatory.
The docuseries does a good job of debunking the 2019 “EVALI” panic, which linked vaping to lung injuries but was later traced to unregulated THC cartridges, not Juul products. But it doesn’t spend enough time grappling with the long-term health impacts of nicotine on developing brains, a subject that remains a contentious and unresolved debate.

One of the most fascinating aspects of Big Vape is how it frames Juul’s story as a microcosm of Silicon Valley’s broader ethos. The company’s rise and fall mirror those of other tech darlings—Theranos, WeWork, Facebook—that promised to change the world but ended up causing more harm than good. Director R.J.
Cutler, whose previous work includes The September Issue and Billie Eilish: The World’s a Little Blurry, has a knack for capturing the seductive allure of these narratives. He doesn’t just show us the facts; he shows us the mythos, the way Juul’s founders and investors bought into their own hype. There’s a moment in the series where David Pierce, a former tech reporter for Wired, describes Juul’s product as “the most beautiful e-cigarette ever made.” It’s a small detail, but it speaks volumes.
Beauty, in this context, isn’t just aesthetic. It’s a sales pitch, a way to make addiction feel aspirational.
The docuseries also raises uncomfortable questions about the role of regulation in the tech industry. Juul’s downfall wasn’t just the result of bad decisions; it was the result of a regulatory system that was slow to catch up to the company’s rapid growth. By the time the FDA and state attorneys general started cracking down, Juul had already hooked a generation of teens.
The series doesn’t offer easy answers, but it does make one thing clear: when companies move fast and break things, it’s not just code that gets shattered. It’s lives.
I’ll admit, I went into Big Vape expecting a straightforward takedown. What I got was something more nuanced—a story about how good intentions can curdle into something toxic, and how the pursuit of innovation can sometimes feel indistinguishable from exploitation. The series doesn’t let Juul off the hook, but it also doesn’t pretend that the company’s story exists in a vacuum.
It’s a story about capitalism, about public health, about the way we mythologize tech founders and then tear them down when their creations spiral out of control. And it’s a story that feels uncomfortably relevant, even if the specifics are unique to Juul.
In the end, Big Vape is less about the rise and fall of a company and more about the rise and fall of an idea: that disruption, in and of itself, is a virtue. The series leaves us with a question that lingers long after the credits roll: What happens when the thing you’re disrupting isn’t an industry, but people’s lives? The answer, it turns out, isn’t pretty.
But it’s one we need to see.
Netflix’s Big Vape: The Rise and Fall of Juul (2023) isn’t just another Silicon Valley cautionary tale—it’s a four-part deep dive into how a sleek e-cigarette startup became a $38 billion juggernaut before collapsing under legal fire and public outrage. The docuseries, based on journalist Jamie Ducharme’s 2021 book Big Vape: The Incendiary Rise of Juul, arrives with built-in controversy: critics argue it either exposes corporate malfeasance or misrepresents the vaping industry’s complexities. latestnetflix.com's read is that Either way, the series has reignited debates about Juul’s role in the teen vaping epidemic and the ethics of tech-driven addiction.
The series traces Juul’s origins as a spin-off from Pax Labs, a company co-founded by Adam Bowen and James Monsees, two Stanford design graduates who pitched their e-cigarette as a harm-reduction tool for adult smokers. Early episodes highlight the company’s rapid ascent, fueled by venture capital and a viral marketing campaign that leaned into sleek design and social media savvy. By 2018, Juul controlled 75% of the U.S. E-cigarette market, with a valuation surpassing $38 billion.
But Big Vape doesn’t shy away from the darker side of that growth. The docuseries zeroes in on accusations that Juul deliberately targeted teens with flavors like mango and cucumber, while downplaying nicotine’s addictive risks. Former employees, regulators, and public health experts appear on camera, painting a picture of a company that prioritized growth over safety—a narrative that aligns with the FDA’s later crackdown on Juul’s products.
The latter half of the series chronicles Juul’s downfall, which unfolded almost as quickly as its rise. By 2019, the company faced lawsuits from nearly every U.S. State, a federal investigation, and a ban on most of its flavored pods. The docuseries frames these events as inevitable consequences of Juul’s aggressive tactics, though some critics argue it oversimplifies the regulatory and scientific debates around vaping.
One standout detail: the series includes footage of Juul’s early ads, which critics say resembled tech product launches more than public health campaigns. The company’s pivot to damage control—including a $438.5 million settlement with 33 states in 2022—is presented as too little, too late.
The docuseries’ origins are almost as dramatic as its subject. Ducharme’s book, Big Vape: The Incendiary Rise of Juul, was optioned by Netflix after its 2021 release, with the streaming giant adapting it into the four-part series. Ducharme herself has been vocal about the challenges of condensing years of reporting into a bingeable format, though she’s praised the series for staying true to the book’s core themes.
As for the cast, journalist David Pierce appears as a key on-screen presence, guiding viewers through Juul’s rise and fall. Other figures, including former Juul employees and public health officials, provide firsthand accounts, though their identities are largely kept to the snippets available in the evidence.
Not everyone is sold on Big Vape’s take. Vaping advocates argue the series glosses over the potential benefits of e-cigarettes for adult smokers looking to quit. One review from Vape Green calls the docuseries "a one-sided hit piece" that ignores Juul’s early harm-reduction claims. Meanwhile, public health experts have praised the series for exposing Juul’s marketing to teens, though some note it stops short of offering solutions to the vaping epidemic it helped create.
Big Vape: The Rise and Fall of Juul is a gripping, if imperfect, look at one of Silicon Valley’s most infamous flameouts. It’s a story of ambition, addiction, and the consequences of unchecked growth—one that resonates far beyond the vaping industry. Whether it’s a fair portrayal or a sensationalized takedown depends on who you ask, but it’s undeniably a conversation starter.
For now, the series stands as a cautionary tale about the dangers of prioritizing profit over people—and the price of playing fast and loose with public health.
Entertainment rumors and trivia aggregated from public reporting. Treat speculation as unverified unless a cited source confirms it.
More titles in the same genres and with the same cast.